◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Yubo International Biotech Ltd

CIK: 895464 SIC: 3845
$12.35K
Revenue
$-1.15M
Net Income
66.10%
Gross Margin
-10625.76%
Op. Margin
$-1.59M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 14 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $12.35K $12.35K $3.47K $604.68K $104.28K $1.24M
Revenue Growth % 0.0% 256.0% -99.4% 479.8% -91.6% nan%
Cost of Revenue $4.19K $4.19K $822.00 $185.49K $51.63K $423.73K
+ Gross Profit $8.16K $8.16K $2.65K $419.19K $52.65K $820.65K
Gross Margin % 66.1% 66.1% 76.3% 69.3% 50.5% 65.9%
Operating Expenses $1.32M $1.20M $1.77M $1.61M $1.26M $2.37M
+ Operating Income $-1.31M $-1.19M $-1.77M $-1.19M $-1.21M $-1.54M
Operating Margin % -10625.8% -9614.6% -51006.3% -197.6% -1155.7% -124.0%
Interest Expense $41.00 - - - - -
Other Income/Expense $-243.00 $-243.00 $-211.87K $-377.00 $229.00 $427.00
Income Before Tax $-1.31M $-1.19M $-1.98M $-1.20M $-1.20M $-1.54M
Income Tax Expense - - - - - -
+ Net Income $-1.15M $-1.08M $-1.98M $-1.20M $-1.20M $-1.54M
Net Margin % -9334.4% -8736.7% -57112.2% -197.6% -1155.5% -124.0%
Diluted EPS nan -0.01 -0.02 -0.10 nan nan
Diluted Shares Outstanding 10.4M 139.6M 119.8M 12.0M - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $8.06K - - - $27.52K
Accounts Receivable $138.04K $164.98K $79.65K $51.93K $161.96K
Inventory $24.03K $36.95K $214.57K $322.17K $164.30K
Total Current Assets $667.51K $682.75K $725.24K $750.01K $1.06M
Property Plant & Equipment $43.03K $205.91K $375.21K $616.65K $643.87K
Intangible Assets $42.08K $50.52K $54.41K $67.68K $38.88K
Total Assets $847.09K $1.53M $1.67M $2.35M $4.59M
Total Current Liabilities $2.79M $4.72M $3.40M $2.52M $2.79M
Total Liabilities $2.79M $4.83M $3.51M $2.91M $4.72M
Retained Earnings $-7.74M $-6.66M $-4.89M $-3.69M $-2.49M
Total Stockholders Equity $-1.95M $-3.42M $-1.84M $-565.37K $-131.20K
Total Liabilities & Equity $847.09K $1.53M $1.67M $2.35M $4.59M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $-1.15M $-1.08M $-1.98M $-1.20M $-1.20M $-1.54M
Depreciation & Amortization $208.84K $167.58K $169.88K $178.31K $18.10K $21.40K
Change in Receivables - $-26.94K $85.33K $-27.72K $-110.03K $-159.64K
Change in Inventory - $-12.92K $-177.62K $107.60K $157.87K $-97.16K
Operating Cash Flow $-1.59M $-842.80K $-1.34M $-738.97K $68.23K $-1.02M
Capital Expenditure - - - - - $564.72K
Investing Cash Flow $73.72K - $118.43K - $-39.77K $-564.72K
Financing Cash Flow $1.60M $849.54K $1.41M $745.66K - $127.16K
Net Change in Cash $7.21K $1.05K $656.00 $-11.86K $-9.30K $-1.36M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue - - - $3.49K
Cost of Revenue - - - $827.00
Gross Profit - - - $2.66K
Operating Expenses $310.13K $532.76K $902.23K $1.42M
Operating Income $-310.13K $-532.76K $-902.23K $-1.41M
Interest Expense $18.00 $49.00 $60.00 $52.00
Other Income/Expense $-18.00 $-88.29K $-60.00 $-216.28K
Income Before Tax $-310.15K $-621.05K $-902.29K $-1.63M
Income Tax Expense - - - -
Net Income $-310.15K $-621.05K $-902.29K $-1.63M
Diluted EPS 0.00 -0.01 -0.01 -0.01
Diluted Shares Outstanding $147.87M $119.82M $129.27M $119.82M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Accounts Receivable $114.29K $164.98K
Inventory $37.89K $36.95K
Total Current Assets $649.56K $682.75K
Property Plant & Equipment $84.64K $205.91K
Intangible Assets $43.24K $50.52K
Total Assets $953.21K $1.53M
Total Current Liabilities $2.56M $4.72M
Total Liabilities $2.56M $4.83M
Retained Earnings $-7.48M $-6.66M
Total Stockholders Equity $-1.66M $-3.42M
Total Liabilities & Equity $953.21K $1.53M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-310.15K $-621.05K $-902.29K $-1.63M
Depreciation & Amortization $41.89K $45.99K $124.90K $130.71K
Operating Cash Flow - - $-714.05K $-405.02K
Investing Cash Flow - - $79.90K $118.43K
Financing Cash Flow - - $473.92K $297.76K
Net Change in Cash - - $3.91K $1.68K

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...